Corrigan Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,862
| Closed | -$311K | – | 43 |
|
|
2023
Q2 | $311K | Buy |
4,862
+1
| +0% | +$67 | 0.1% | 59 |
|
|
2023
Q1 | $337K | Buy |
4,861
+1
| +0% | +$71 | 0.11% | 58 |
|
|
2022
Q4 | $350K | Sell |
4,860
-36
| -0.7% | -$2.71K | 0.13% | 56 |
|
|
2022
Q3 | $348K | Buy |
4,896
+174
| +4% | +$12.6K | 0.13% | 53 |
|
|
2022
Q2 | $364K | Buy |
4,722
+1
| +0% | +$76 | 0.13% | 52 |
|
|
2022
Q1 | $345K | Buy |
4,721
+1
| +0% | +$67 | 0.11% | 61 |
|
|
2021
Q4 | $294K | Buy |
4,720
+2
| +0% | +$117 | 0.08% | 65 |
|
|
2021
Q3 | $279K | Buy |
4,718
+1
| +0% | +$66 | 0.09% | 63 |
|
|
2021
Q2 | $315K | Sell |
4,717
-103
| -2% | -$6.72K | 0.1% | 60 |
|
|
2021
Q1 | $304K | Sell |
4,820
-101
| -2% | -$6.28K | 0.1% | 57 |
|
|
2020
Q4 | $305K | Buy |
4,921
+559
| +13% | +$34.4K | 0.13% | 52 |
|
|
2020
Q3 | $263K | Buy |
4,362
+2
| +0% | +$120 | 0.13% | 50 |
|
|
2020
Q2 | $256K | Sell |
4,360
-398
| -8% | -$23.8K | 0.14% | 47 |
|
|
2020
Q1 | $265K | Buy |
4,758
+2
| +0% | +$122 | 0.19% | 46 |
|
|
2019
Q4 | $305K | Buy |
4,756
+108
| +2% | +$6.18K | 0.21% | 44 |
|
|
2019
Q3 | $236K | Buy |
4,648
+2
| +0% | +$94 | 0.18% | 51 |
|
|
2019
Q2 | $211K | Sell |
4,646
-2,297
| -33% | -$107K | 0.16% | 61 |
|
|
2019
Q1 | $331K | Buy |
6,943
+2,239
| +48% | +$112K | 0.24% | 42 |
|
|
2018
Q4 | $245K | Buy |
4,704
+248
| +6% | +$13.3K | 0.2% | 40 |
|
|
2018
Q3 | $277K | Sell |
4,456
-297
| -6% | -$17.6K | 0.2% | 36 |
|
|
2018
Q2 | $263K | Buy |
4,753
+4
| +0.1% | +$216 | 0.2% | 36 |
|
|
2018
Q1 | $300K | Buy |
4,749
+3
| +0.1% | +$193 | 0.23% | 31 |
|
|
2017
Q4 | $291K | Buy |
4,746
+119
| +3% | +$7.44K | 0.24% | 33 |
|
|
2017
Q3 | $295K | Buy |
4,627
+106
| +2% | +$6.19K | 0.26% | 34 |
|
|
2017
Q2 | $252K | Buy |
+4,521
| New | +$246K | 0.23% | 35 |
|
|
2016
Q3 | – | Sell |
-3,019
| Closed | -$222K | – | 41 |
|
|
2016
Q2 | $222K | Buy |
+3,019
| New | +$213K | 0.23% | 35 |
|
|
2016
Q1 | – | Sell |
-2,981
| Closed | -$205K | – | 47 |
|
|
2015
Q4 | $205K | Buy |
+2,981
| New | +$197K | 0.22% | 34 |
|
Other funds holding BMY
Corrigan Financial's BMY Position: Q3 2023 in Review
Corrigan Financial sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 4,862 shares — an estimated $311K sold.
Corrigan Financial first reported a position in BMY in Q4 2015 and held it in 27 quarters. The position peaked at $364K in Q2 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Corrigan Financial reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- Corrigan Financial sold 4,862 Bristol-Myers Squibb shares in Q3 2023, an estimated $311K.
- Corrigan Financial first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 27 quarters.
- Corrigan Financial's Bristol-Myers Squibb position peaked at $364K in Q2 2022.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Corrigan Financial's 13F filing for Q3 2023, filed 16 Oct 2023.